Skip to main content
Press Release/Announcement

Nimodipine Capsules (marketed as Nimotop).

MedWatch Safety Alert. Rockville, MD: US Food and Drug Administration; January 1, 2006.

Save
Print
March 1, 2006
MedWatch Safety Alert. Rockville, MD: US Food and Drug Administration; January 1, 2006.

This U.S. Food and Drug Administration alert reminds health care professionals that nimodipine should only be administered orally, and that intravenous or parenteral administration can cause serious adverse events.